Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects

NCT01846455 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Failure
Hepatic Impairment
Chronic Hepatitis C Infection With Hepatic Coma

Interventions

DRUG: 2.0mg Buprenorphine/0.5mg Naloxone
DRUG: Promethazine

Sponsor

Indivior Inc.